Table of Contents
Table 5-19: Dubois
Table 5-21: Fayette
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 375 | 489.5 | 1,751 | 483.2 | 173 | 232.2 | 801 | 231.3 |
| Esophagus | 13 | 16.9** | 33 | 9.1 | 5 | 7.6** | 25 | 7.1 |
| Stomach | 6 | 7.7** | 29 | 7.8 | 6 | 7.2** | 20 | 5.3 |
| Colon excluding Rectum | 35 | 45.2 | 164 | 47.6 | 14 | 17.5** | 57 | 17.0 |
| Rectum and Rectosigmoid Junction | 8 | 11.7** | 58 | 16.8 | * | # | 15 | 4.4** |
| Liver | * | # | 16 | 4.3** | * | # | 13 | 3.4** |
| Pancreas | 8 | 11.0** | 41 | 11.4 | 9 | 12.5** | 36 | 10.3 |
| Lung and Bronchus | 85 | 108.8 | 345 | 96.7 | 58 | 78.5 | 276 | 79.4 |
| Melanoma of the Skin | 19 | 24.6** | 74 | 20.2 | * | # | 17 | 4.8** |
| Prostate | 85 | 115.2 | 408 | 114.5 | 13 | 19.5** | 70 | 22.4 |
| Urinary Bladder | 19 | 26.8** | 90 | 25.8 | * | # | 23 | 7.0 |
| Kidney and Renal Pelvis | 8 | 10.2** | 51 | 13.2 | 6 | 6.5** | 22 | 5.4 |
| Brain and Other Nervous System | * | # | 26 | 6.2 | * | # | 24 | 6.0 |
| Non-Hodgkin Lymphoma | 16 | 20.3** | 83 | 21.9 | 7 | 10.2** | 42 | 12.2 |
| Myeloma | 9 | 12.3** | 24 | 6.7 | * | # | 13 | 3.9** |
| Leukemia | 8 | 10.2** | 56 | 15.4 | 7 | 10.3** | 34 | 10.4 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 372 | 390.8 | 1,919 | 415.4 | 147 | 151.1 | 765 | 160.4 |
| Colon excluding Rectum | 39 | 39.4 | 174 | 36.5 | 6 | 5.6** | 55 | 11.0 |
| Rectum and Rectosigmoid Junction | 13 | 13.4** | 59 | 12.7 | * | # | 12 | 2.5** |
| Liver | * | # | 3 | # | * | # | 6 | 1.3** |
| Pancreas | 7 | 7.3** | 39 | 8.2 | 6 | 5.9** | 41 | 8.4 |
| Lung and Bronchus | 55 | 58.3 | 241 | 52.6 | 42 | 43.8 | 185 | 39.6 |
| Melanoma of the Skin | 11 | 11.9** | 47 | 10.4 | * | # | 7 | 1.5** |
| Breast | 79 | 84.1 | 533 | 116.3 | 26 | 26.6 | 108 | 22.7 |
| Cervix Uteri | 12 | 13.3** | 42 | 9.3 | * | # | 15 | 3.4** |
| Corpus Uteri | 28 | 30.1 | 159 | 35.1 | * | # | 11 | 2.4** |
| Ovary | 17 | 17.9** | 73 | 15.7 | 9 | 9.3** | 44 | 9.0 |
| Urinary Bladder | 15 | 14.6** | 50 | 10.3 | * | # | 13 | 2.6** |
| Kidney and Renal Pelvis | 14 | 14.5** | 53 | 11.4 | * | # | 23 | 4.6 |
| Brain and Other Nervous System | 5 | 5.1** | 30 | 6.4 | 6 | 6.3** | 20 | 4.3 |
| Non-Hodgkin Lymphoma | 16 | 16.9** | 82 | 17.6 | 6 | 6.1** | 31 | 6.6 |
| Myeloma | * | # | 13 | 2.7** | * | # | 17 | 3.5** |
| Leukemia | * | # | 47 | 10.0 | 5 | 4.8** | 30 | 6.4 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-19: Dubois
Table 5-21: Fayette
